TrialThe New England journal of medicine2014
Effects of extended-release niacin with laropiprant in high-risk patients.
HPS2-THRIVE Collaborative Group et al.PubMed ↗Publisher ↗
The primary results report of NCT00461630.
No numbers read from the abstract.
605 papers cite itlatest 60 shown
this paperpooled ittrialcites it